MedTrace Logo

Microbial and Cytokine Signatures in Long COVID Patients

NCT07074158 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-07-20

No results posted yet for this study

Summary

We aim at identifying potential biomarkers in plasma indicative of post-acute coronavirus SARS-CoV-2 Syndrome (Long COVID). Our case-control study will compare Long COVID patients to healthy patients from Sutter Health.

Conditions

  • Post-Acute COVID-19 Syndrome

Sponsors & Collaborators

  • Palo Alto Medical Foundation

    lead OTHER

Principal Investigators

  • Jose G Montoya · Sutter Health, Palo Alto Medical Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-14
Primary Completion
2026-07-13
Completion
2026-10-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07074158 on ClinicalTrials.gov